BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

733 related articles for article (PubMed ID: 30515821)

  • 1. Dynamin-related protein 1: A critical protein in the pathogenesis of neural system dysfunctions and neurodegenerative diseases.
    Qi Z; Huang Z; Xie F; Chen L
    J Cell Physiol; 2019 Jul; 234(7):10032-10046. PubMed ID: 30515821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamics of Dynamin-Related Protein 1 in Alzheimer's Disease and Other Neurodegenerative Diseases.
    Oliver D; Reddy PH
    Cells; 2019 Aug; 8(9):. PubMed ID: 31450774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dynamin-related protein 1 and mitochondrial fragmentation in neurodegenerative diseases.
    Reddy PH; Reddy TP; Manczak M; Calkins MJ; Shirendeb U; Mao P
    Brain Res Rev; 2011 Jun; 67(1-2):103-18. PubMed ID: 21145355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial dysfunction, mitophagy, and role of dynamin-related protein 1 in Alzheimer's disease.
    Medala VK; Gollapelli B; Dewanjee S; Ogunmokun G; Kandimalla R; Vallamkondu J
    J Neurosci Res; 2021 Apr; 99(4):1120-1135. PubMed ID: 33465841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
    Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
    J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduced dynamin-related protein 1 protects against phosphorylated Tau-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Kandimalla R; Manczak M; Fry D; Suneetha Y; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Nov; 25(22):4881-4897. PubMed ID: 28173111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective effects of reduced dynamin-related protein 1 against amyloid beta-induced mitochondrial dysfunction and synaptic damage in Alzheimer's disease.
    Manczak M; Kandimalla R; Fry D; Sesaki H; Reddy PH
    Hum Mol Genet; 2016 Dec; 25(23):5148-5166. PubMed ID: 27677309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S-nitrosylation of dynamin-related protein 1 mediates mutant huntingtin-induced mitochondrial fragmentation and neuronal injury in Huntington's disease.
    Haun F; Nakamura T; Shiu AD; Cho DH; Tsunemi T; Holland EA; La Spada AR; Lipton SA
    Antioxid Redox Signal; 2013 Oct; 19(11):1173-84. PubMed ID: 23641925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased O-GlcNAcylation of Drp1 by amyloid-beta promotes mitochondrial fission and dysfunction in neuronal cells.
    Park SJ; Bae JE; Jo DS; Kim JB; Park NY; Fang J; Jung YK; Jo DG; Cho DH
    Mol Brain; 2021 Jan; 14(1):6. PubMed ID: 33422108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanistic and therapeutic role of Drp1 in the pathogenesis of Alzheimer's disease.
    Bera A; Lavanya G; Reshmi R; Dev K; Kumar R
    Eur J Neurosci; 2022 Nov; 56(9):5516-5531. PubMed ID: 35078269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aβ-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis.
    Kim DI; Lee KH; Gabr AA; Choi GE; Kim JS; Ko SH; Han HJ
    Biochim Biophys Acta; 2016 Nov; 1863(11):2820-2834. PubMed ID: 27599716
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple faces of dynamin-related protein 1 and its role in Alzheimer's disease pathogenesis.
    Kandimalla R; Reddy PH
    Biochim Biophys Acta; 2016 Apr; 1862(4):814-828. PubMed ID: 26708942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting dynamin-related protein-1 as a potential therapeutic approach for mitochondrial dysfunction in Alzheimer's disease.
    Bhatti JS; Kaur S; Mishra J; Dibbanti H; Singh A; Reddy AP; Bhatti GK; Reddy PH
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166798. PubMed ID: 37392948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amyloid Beta and Phosphorylated Tau-Induced Defective Autophagy and Mitophagy in Alzheimer's Disease.
    Reddy PH; Oliver DM
    Cells; 2019 May; 8(5):. PubMed ID: 31121890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blockage of GSK3β-mediated Drp1 phosphorylation provides neuroprotection in neuronal and mouse models of Alzheimer's disease.
    Yan J; Liu XH; Han MZ; Wang YM; Sun XL; Yu N; Li T; Su B; Chen ZY
    Neurobiol Aging; 2015 Jan; 36(1):211-27. PubMed ID: 25192600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant huntingtin's interaction with mitochondrial protein Drp1 impairs mitochondrial biogenesis and causes defective axonal transport and synaptic degeneration in Huntington's disease.
    Shirendeb UP; Calkins MJ; Manczak M; Anekonda V; Dufour B; McBride JL; Mao P; Reddy PH
    Hum Mol Genet; 2012 Jan; 21(2):406-20. PubMed ID: 21997870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The distinctive role of tau and amyloid beta in mitochondrial dysfunction through alteration in Mfn2 and Drp1 mRNA Levels: A comparative study in Drosophila melanogaster.
    Abtahi SL; Masoudi R; Haddadi M
    Gene; 2020 Sep; 754():144854. PubMed ID: 32525045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal interaction between the mitochondrial fission protein Drp1 and hyperphosphorylated tau in Alzheimer's disease neurons: implications for mitochondrial dysfunction and neuronal damage.
    Manczak M; Reddy PH
    Hum Mol Genet; 2012 Jun; 21(11):2538-47. PubMed ID: 22367970
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutant huntingtin, abnormal mitochondrial dynamics, defective axonal transport of mitochondria, and selective synaptic degeneration in Huntington's disease.
    Reddy PH; Shirendeb UP
    Biochim Biophys Acta; 2012 Feb; 1822(2):101-10. PubMed ID: 22080977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial fission mediated by Drp1-Fis1 pathway and neurodegenerative diseases.
    Shi W; Tan C; Liu C; Chen D
    Rev Neurosci; 2023 Apr; 34(3):275-294. PubMed ID: 36059131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.